Successful treatment of massive pulmonary embolism with reteplase

Turk Kardiyol Dern Ars. 2018 Mar;46(2):143-146. doi: 10.5543/tkda.2017.33568.

Abstract

Unexpected and unexplained out-of-hospital cardiac arrests have a poor prognosis. Difficulties encountered during the differential diagnosis phase may delay the administration of specific treatment for treatable and reversible causes of cardiac arrest. Massive pulmonary embolism is a reversible cause of cardiac arrest, but without proper management it has a high mortality rate. Presently described is the case of a 53-year-old female patient with a massive pulmonary embolism.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Fibrinolytic Agents* / administration & dosage
  • Fibrinolytic Agents* / therapeutic use
  • Heart Arrest / etiology
  • Humans
  • Middle Aged
  • Pulmonary Embolism* / complications
  • Pulmonary Embolism* / diagnosis
  • Pulmonary Embolism* / drug therapy
  • Pulmonary Embolism* / physiopathology
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Tissue Plasminogen Activator* / administration & dosage
  • Tissue Plasminogen Activator* / therapeutic use
  • Tomography, X-Ray Computed

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • reteplase
  • Tissue Plasminogen Activator